Fawza Monem

449 total citations
33 papers, 316 citations indexed

About

Fawza Monem is a scholar working on Epidemiology, Hepatology and Molecular Biology. According to data from OpenAlex, Fawza Monem has authored 33 papers receiving a total of 316 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Epidemiology, 11 papers in Hepatology and 6 papers in Molecular Biology. Recurrent topics in Fawza Monem's work include Hepatitis B Virus Studies (10 papers), Hepatitis C virus research (10 papers) and Liver Disease Diagnosis and Treatment (5 papers). Fawza Monem is often cited by papers focused on Hepatitis B Virus Studies (10 papers), Hepatitis C virus research (10 papers) and Liver Disease Diagnosis and Treatment (5 papers). Fawza Monem collaborates with scholars based in Syria, Puerto Rico and Germany. Fawza Monem's co-authors include Barbara C. Gärtner, Sara Barbuto, Bruce J. Paster, Jasim M. Albandar, Hyam Bashour, Ammar Madania, Marwan Alhalabi and Gert Frösner and has published in prestigious journals such as Annals of Oncology, Journal of Periodontology and Journal of Medical Microbiology.

In The Last Decade

Fawza Monem

32 papers receiving 294 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fawza Monem Syria 11 160 111 44 37 34 33 316
G Santini Italy 10 186 1.2× 211 1.9× 99 2.3× 51 1.4× 57 1.7× 30 444
Manuel Lecona Spain 11 109 0.7× 21 0.2× 29 0.7× 11 0.3× 52 1.5× 19 291
Maria Inês de Moura Campos Pardini Brazil 13 113 0.7× 118 1.1× 65 1.5× 66 1.8× 13 0.4× 42 374
Cathy Schechterly United States 9 120 0.8× 193 1.7× 82 1.9× 24 0.6× 17 0.5× 12 350
Choong‐Hwan Cha South Korea 11 96 0.6× 28 0.3× 73 1.7× 73 2.0× 42 1.2× 30 299
Minjun Chung United States 7 272 1.7× 354 3.2× 45 1.0× 16 0.4× 110 3.2× 8 412
Stephen Delaney United States 12 163 1.0× 173 1.6× 31 0.7× 113 3.1× 18 0.5× 19 380
Noureddine Berka Canada 10 148 0.9× 25 0.2× 53 1.2× 187 5.1× 16 0.5× 60 429
Denise Bundow United States 7 81 0.5× 17 0.2× 87 2.0× 76 2.1× 64 1.9× 12 340
Christoffer Dellgren Denmark 6 102 0.6× 124 1.1× 40 0.9× 207 5.6× 73 2.1× 11 555

Countries citing papers authored by Fawza Monem

Since Specialization
Citations

This map shows the geographic impact of Fawza Monem's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fawza Monem with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fawza Monem more than expected).

Fields of papers citing papers by Fawza Monem

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fawza Monem. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fawza Monem. The network helps show where Fawza Monem may publish in the future.

Co-authorship network of co-authors of Fawza Monem

This figure shows the co-authorship network connecting the top 25 collaborators of Fawza Monem. A scholar is included among the top collaborators of Fawza Monem based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fawza Monem. Fawza Monem is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Monem, Fawza, et al.. (2023). Bioinformatic analysis of KIT juxtamembrane domain mutations in Syrian GIST patients: jigsaw puzzle completed. Journal of the Egyptian National Cancer Institute. 35(1). 25–25. 2 indexed citations
2.
Monem, Fawza, et al.. (2021). 16P Repurposing rosiglitazone with chemotherapy in breast cancer: A sequence-specific synergy?. Annals of Oncology. 32. S365–S365. 1 indexed citations
3.
Monem, Fawza, et al.. (2021). EBV Plasma Epstein-Barr Virus (EBV) DNA as a Biomarker for Diagnosis of EBV-positive Hodgkin Lymphoma in Syria. The Journal of Infection in Developing Countries. 15(12). 1917–1922. 9 indexed citations
5.
Monem, Fawza, et al.. (2018). Association Between STAT4 rs7574865 Polymorphism and Rheumatoid Arthritis: Debate Unresolved. The Open Rheumatology Journal. 12(1). 172–178. 7 indexed citations
6.
Monem, Fawza, et al.. (2016). Seropositivity of Hepatitis B and C among Syrian Multitransfused Patients. Mediterranean Journal of Hematology and Infectious Diseases. 8(1). e2016046–e2016046. 8 indexed citations
7.
Monem, Fawza, et al.. (2015). Screening of GJB6 Gene Large Deletions Among Syrians with Congenital Hearing Impairment. Genetic Testing and Molecular Biomarkers. 19(7). 405–407. 3 indexed citations
8.
Monem, Fawza, et al.. (2014). Prevalence of "anti-HBc alone" among Syrian blood donors. The Journal of Infection in Developing Countries. 8(8). 1013–1015. 12 indexed citations
9.
Monem, Fawza, et al.. (2014). Hepatitis B Splice-Generated Protein Antibodies in Syrian Chronic Hepatitis B Patients: Incidence and Significance. Hepatitis Monthly. 14(4). e13166–e13166. 2 indexed citations
10.
Monem, Fawza, et al.. (2013). Significance of screening antibodies to hepatitis B virus core antigen among Syrian blood donors. Transfusion Medicine. 23(4). 265–268. 10 indexed citations
11.
Alhalabi, Marwan, et al.. (2013). High prevalence of genetic abnormalities in Middle Eastern patients with idiopathic non-obstructive azoospermia. Journal of Assisted Reproduction and Genetics. 30(6). 799–805. 16 indexed citations
12.
Monem, Fawza, et al.. (2012). Brucellosis laboratory tests in Syria: what are their diagnostic efficacies in different clinical manifestations?. The Journal of Infection in Developing Countries. 6(6). 495–500. 11 indexed citations
13.
Monem, Fawza, et al.. (2012). Rethinking therapeutic decisions for hepatitis B infection in Syria: insights into molecular monitoring. The Journal of Infection in Developing Countries. 6(10). 744–747. 3 indexed citations
14.
Monem, Fawza, et al.. (2011). Utility of an interferon-gamma release assay as a potential diagnostic aid for active pulmonary tuberculosis. The Journal of Infection in Developing Countries. 6(1). 67–72. 12 indexed citations
15.
Albandar, Jasim M., et al.. (2011). The Subgingival Microbiota of Papillon‐Lefèvre Syndrome. Journal of Periodontology. 83(7). 902–908. 26 indexed citations
16.
Monem, Fawza, et al.. (2011). Are human herpes viruses associated with autoimmune thyroid disease?. The Journal of Infection in Developing Countries. 5(12). 890–892. 10 indexed citations
17.
Monem, Fawza, et al.. (2009). Is low birth weight a risk indicator for congenital cytomegalovirus infection?. The Journal of Infection in Developing Countries. 4(1). 44–47. 14 indexed citations
18.
Monem, Fawza, et al.. (2007). Prevalence of factor V Leiden mutation and its relation with recurrent spontaneous pregnancy loss in a group of Syrian women.. Middle East Fertility Society Journal. 12(3). 6 indexed citations
19.
Monem, Fawza, et al.. (2002). Prevalence of hepatitis C virus antibodies among intravenous drug abusers and prostitutes in Damascus, Syria.. PubMed. 23(4). 393–5. 33 indexed citations
20.
Frösner, Gert, et al.. (1999). Hepatitis E in Damascus, Syria. Infection. 27(3). 221–223. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026